Search results
Study: High excess death rates in the West for 3 years running since start of pandemic despite...
Medical Xpress· 1 day agoExcess death rates have remained high in the West for three years running since the start of the COVID-19 pandemic, finds a data analysis of 47 countries published in BMJ Public Health. This ...
Why it's so challenging to develop vaccines for parasitic diseases
BBC News· 14 hours agoThe process of making vaccines for parasites is extremely challenging – but scientists might be on...
Study: Development of a vaccine will best protect humans from bird flu
United Press International via Yahoo News· 6 days agoOverall, the team suggests "exploring and employing a diverse range of vaccine platforms "will be...
'Exciting' skin cancer vaccine halves risk of relapse or death in study
Daily Express· 1 day agoA cutting-edge skin cancer vaccine being trialled on NHS patients halves the risk of death or...
Exploring how parental decisions on vaccines can be swayed by social media
Medical Xpress· 6 hours agoThe paper, "Exploring social media influences on vaccine decision-making in parents: a netnography,"...
Melanoma skin cancer vaccine being trialled on NHS halves risk of death or relapse
Daily Telegraph· 1 day agoMeanwhile, another study by the Danish biotech firm Evaxion and the Melanoma Institute Australia at...
Study: Development of a vaccine will best protect humans from bird flu
UPI· 6 days agoHumanity's best protection against bird flu will be the development of effective vaccines, a new ...
Vaccines Will Be Best Defense Against Bird Flu, Experts Say | FOX 28 Spokane
FOX 28 Spokane· 7 days agoHumanity’s best protection against bird flu will be the development of effective vaccines, a new ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 1 day agoThe vaccine together with Merck's Keytruda improved survival and showed long-lasting efficacy in a...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 6 hours agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...